🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 134 of 173

  1. US 7442546

    Method of modulating inflammatory response

    Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7442558

    Phthalamide-lanthanide complexes for use as luminescent markers

    Expires Mon Oct 23 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7438931

    Methods and compositions for the treatment of angiogenic diseases

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7438914

    Composition and method for enhancing immune response

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7439265

    Irciniastatins a and b

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7439323

    Cysteine-containing peptides having antioxidant properties

    Expires Mon Oct 16 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7435755

    CDDO-compounds and combination therapies thereof

    Expires Mon Oct 09 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7432300

    Gossypol co-crystals and the use thereof

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7431929

    Use of vaccinia virus deleted for the E3L gene as a vaccine vector

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7431915

    Peptides whose uptake by cells is controllable

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7432304

    Small molecule antagonists of Bcl-2 family proteins

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7432242

    Inhibitors of RGS proteins

    Expires Mon Oct 02 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7429457

    Id-1 and Id-2 genes and products as markers of epithelial cancer

    Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7429616

    Synthesis and complete stereochemical assignment of psymberin/irciniastatin for use as antitumor compounds

    Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7429596

    1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof

    Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7429387

    Use of botulinum toxin therapy for treatment of recalcitrant voiding dysfunction

    Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7429238

    Systems and methods for the generation of crystalline polymorphs

    Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7427602

    Sustained DNA delivery from structural matrices

    Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7427408

    Quorum sensing and biofilm formation

    Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7427496

    Anti-cancer compounds

    Expires Mon Sep 18 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7425329

    Methods for treating bone cancer pain by administering a nerve growth factor antagonist

    Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7425449

    Site specific Listeria integration vectors and methods for using the same

    Expires Mon Sep 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7422900

    System and method for forming a connective tissue construct

    Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7423066

    Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism

    Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7423015

    Antihelminthic drugs as a treatment for hyperproliferative diseases

    Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7422738

    Combined cancer treatment methods using antibodies to aminophospholipids

    Expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7420100

    Methods and compositions relating to HDAC 4 and 5 regulation of cardiac gene expression

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7420030

    Aminopeptidase A (APA) targeting peptides for the treatment of cancer

    Expires Mon Aug 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7417037

    Compositions and methods of treatment for inflammatory diseases

    Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7417113

    PSCA: prostate stem cell antigen and uses thereof

    Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7416724

    Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway

    Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7416741

    Copper lowering treatment of inflammatory and fibrotic diseases

    Expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7413873

    Method of detection and treatment of colon cancer

    Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7413781

    Gels for encapsulation of biological materials

    Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7413864

    Treating cancer using a telomerase vaccine

    Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7414035

    hKIS composition and methods of use

    Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7414039

    Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

    Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7414037

    Hydrazide-containing CFTR inhibitor compounds and uses thereof

    Expires Mon Aug 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7410950

    Peptides of CaV2.2 that inhibit pain

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7410958

    Triterpene quaternary salts as biologically active surfactants

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7410758

    Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7410665

    Coated implantable medical device

    Expires Mon Aug 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7407939

    Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics

    Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7407656

    PSCA: prostate stem cell antigen and uses thereof

    Expires Mon Jul 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7404954

    Methods of targeting agents to cells expressing the polymeric immunoglobulin receptor

    Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7405314

    Compounds and methods for the treatment of cancer

    Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7405287

    Method of treating a cancer

    Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7405202

    CRISP polypeptides as contraceptives and inhibitors of sperm capacitation

    Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.